Then, they integrated the somatic mutation data for determining the relationship between immunotherapy biomarkers like the tumor mutation burden (TMB), neoantigen expression, and ICG (PD1/PD-L1, CTLA4, etc.)expression, which were widely used as the biomarkers for immunotherapy response. Here, CD274 is linked to neoplasm.